Quebec’s Five Most Interesting Biotech Stocks

Quebec City's Medicago uses tobacco leaves to grow virus-like particles. The particles are then extracted and processed to become vaccines. The company recently opened a 97,000-square-foot complex in North Carolina that can produce a flu vaccine in just thirty days.

BufferIf you want telecom you go to Ottawa. If you want oil and gas technology, go to Alberta. When it comes to biotech, Quebec is Canada’s undisputed champion. Quebec ranks fourth in North America in terms of the number of biotech firms, and all of the world’s top ten pharmaceutical companies all have operations there. [...]

Byron Capital: AEterna Zentaris is a Speculative Buy, Target Price $3.50

In July, nearly eight years after initially filing, AEterna Zentaris’ cancer therapy candidate, perifosine, was granted a patent by the European Patent Office

BufferAfter a tough few years, the first half of 2011 showed signs of hope for shareholders of AEterna Zentaris (TSX:AEZ). In July, nearly eight years after initially filing, the company’s cancer therapy candidate, Perifosine, was granted a patent by the European Patent Office. By the end of that month, the Quebec-based oncology/endocrinology drug maker had [...]

15 Canadian Techs Trading Far Below Analyst Targets

allon

BufferThere are many people who believe Canadian technology stocks are undervalued. Of course, as John Maynard Keynes famously quipped, markets can remain irrational longer than you can remain solvent. Still, with a massive exodus from commodities now fully underway, is it just a matter of time before money starts flowing into Canadian technology stocks, driving [...]

Eight is Enough for AEterna Zentaris; granted European patent for Perifosine

europeanpatentoffice

BufferAfter a tough few years, 2011 is shaping up quite nicely for shareholders of Quebec City’s Aeterna Zentaris (TSX:AEZ). Today, nearly eight years after initially filing, the company’s cancer therapy candidate, Perifosine, was granted a patent by the European Patent Office. The patent, which is effective July 13th and will expire on July 28, 2023, [...]

Should AEterna Zentaris be rising or falling on Japan woes?

aeternazentaris

BufferQuebec City’s AEterna Zentaris (TSX:AEZ), the developer of oncological and endocrine therapies, is really testing the notion of sector negativity these days. The Japanese earthquake and subsequent tsunami has been called the worst catastrophe since World War Two by Japanese PM Naoto Kan. Early estimates for the cost of the cleanup are in the tens [...]

The 100% Club: 15 TSX Techs that Doubled in 2010

Andrew Cheung, President and CEO of 01 Communique.

BufferAnother year, and another year of mining stock successes on the Toronto Stock Exchange. It seems like decades since a technology stock really made a difference to the index, and 2010 was not the year to break that pattern. In fact, only one technology related issue cracked the top thirty five performing stocks on the [...]

Are things finally looking up for AEterna Zentaris?

Jürgen Engel, President & CEO of AEterna Zentaris

BufferEarly this year, things weren’t looking that great for Quebec City’s AEterna Zentaris (TSX:AEZ). On January 21st, the company received notification from the NASDAQ that they didn’t comply with the exchange’s minimum bid price requirements. Shares of AEterna, an oncology and endocrine therapy drug development company with a Phase 3 cancer therapy candidate, Perifosine, had [...]

2010: The Top 20 Canadian Techs (so far) This Year

Electrovaya's Maya-300, a zero-emission, low-speed electric vehicle

Buffer 2010: The Top 20 Canadian Techs (So far) This Year 2009 was a year of recovery for the worldwide markets, and Canadian tech stocks were no exception. Led by DragonWave (TSX:DWI) which began the year as a TSX Venture stock and ended with a full big board listing and a share price in excess [...]